Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Oesophageal cancer, Stomach cancer
Closed
Phase 1
This trial is looking at a new drug called LJM716 alongside trastuzumab (Herceptin) for HER2 positive cancer. It is for people who have breast cancer, stomach cancer or cancer where the food pipe (oesophagus) meets the stomach (gastro oesophageal junction cancer) that has spread to another part of the body.
Recruitment start: 29 June 2013
Recruitment end: 22 September 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Anthony Kong
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 29 Oct 2014
CRUK internal database number: 10695
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
